130 related articles for article (PubMed ID: 34292322)
1. AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.
Morande PE; Yan XJ; Sepulveda J; Seija N; Marquez ME; Sotelo N; Abreu C; Crispo M; Fernández-Graña G; Rego N; Bois T; Methot SP; Palacios F; Remedi V; Rai KR; Buschiazzo A; Di Noia JM; Navarrete MA; Chiorazzi N; Oppezzo P
Blood; 2021 Jul; 138(3):246-258. PubMed ID: 34292322
[TBL] [Abstract][Full Text] [Related]
2. IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.
Patten PE; Chu CC; Albesiano E; Damle RN; Yan XJ; Kim D; Zhang L; Magli AR; Barrientos J; Kolitz JE; Allen SL; Rai KR; Roa S; Mongini PK; MacCarthy T; Scharff MD; Chiorazzi N
Blood; 2012 Dec; 120(24):4802-11. PubMed ID: 23071276
[TBL] [Abstract][Full Text] [Related]
3. Loss of AID exacerbates the malignant progression of CLL.
Lee AC; Pingali SR; Pinilla-Ibarz JA; Atchison ML; Koumenis C; Argon Y; Thomas-Tikhonenko A; De Trez C; Hu CA; Tang CA
Leukemia; 2022 Oct; 36(10):2430-2442. PubMed ID: 36042317
[TBL] [Abstract][Full Text] [Related]
4. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
[TBL] [Abstract][Full Text] [Related]
5. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia.
Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M
Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279
[TBL] [Abstract][Full Text] [Related]
6. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness.
Lewis R; Maurer HC; Singh N; Gonzalez-Menendez I; Wirth M; Schick M; Zhang L; Isaakidis K; Scherger AK; Schulze V; Lu J; Zenz T; Steiger K; Rad R; Quintanilla-Martinez L; Espeli M; Balabanian K; Keller U; Habringer S
Leukemia; 2021 Oct; 35(10):2895-2905. PubMed ID: 34363012
[TBL] [Abstract][Full Text] [Related]
8. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
Palacios F; Moreno P; Morande P; Abreu C; Correa A; Porro V; Landoni AI; Gabus R; Giordano M; Dighiero G; Pritsch O; Oppezzo P
Blood; 2010 Jun; 115(22):4488-96. PubMed ID: 20233972
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.
Kriss CL; Pinilla-Ibarz JA; Mailloux AW; Powers JJ; Tang CH; Kang CW; Zanesi N; Epling-Burnette PK; Sotomayor EM; Croce CM; Del Valle JR; Hu CC
Blood; 2012 Aug; 120(5):1027-38. PubMed ID: 22692508
[TBL] [Abstract][Full Text] [Related]
10. Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas.
Sepulveda-Yanez JH; Alvarez-Saravia D; Fernandez-Goycoolea J; Aldridge J; van Bergen CAM; Posthuma W; Uribe-Paredes R; Veelken H; Navarrete MA
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884820
[TBL] [Abstract][Full Text] [Related]
11. AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.
Huemer M; Rebhandl S; Zaborsky N; Gassner FJ; Hainzl S; Weiss L; Hebenstreit D; Greil R; Geisberger R
Eur J Immunol; 2014 Dec; 44(12):3747-57. PubMed ID: 25179679
[TBL] [Abstract][Full Text] [Related]
12. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
Oppezzo P; Dighiero G
Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
[TBL] [Abstract][Full Text] [Related]
13. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.
Albesiano E; Messmer BT; Damle RN; Allen SL; Rai KR; Chiorazzi N
Blood; 2003 Nov; 102(9):3333-9. PubMed ID: 12855567
[TBL] [Abstract][Full Text] [Related]
14. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
15. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
[TBL] [Abstract][Full Text] [Related]
16. Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia.
Walker JS; Hing ZA; Harrington B; Baumhardt J; Ozer HG; Lehman A; Giacopelli B; Beaver L; Williams K; Skinner JN; Cempre CB; Sun Q; Shacham S; Stromberg BR; Summers MK; Abruzzo LV; Rassenti L; Kipps TJ; Parikh S; Kay NE; Rogers KA; Woyach JA; Coppola V; Chook YM; Oakes C; Byrd JC; Lapalombella R
J Hematol Oncol; 2021 Jan; 14(1):17. PubMed ID: 33451349
[TBL] [Abstract][Full Text] [Related]
17. Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
Nganga VK; Palmer VL; Naushad H; Kassmeier MD; Anderson DK; Perry GA; Schabla NM; Swanson PC
Blood; 2013 May; 121(19):3855-66, S1-16. PubMed ID: 23502221
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
19. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.
Yan XJ; Albesiano E; Zanesi N; Yancopoulos S; Sawyer A; Romano E; Petlickovski A; Efremov DG; Croce CM; Chiorazzi N
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11713-8. PubMed ID: 16864779
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients.
Öztürk S; Paul Y; Afzal S; Gil-Farina I; Jauch A; Bruch PM; Kalter V; Hanna B; Arseni L; Roessner PM; Schmidt M; Stilgenbauer S; Dietrich S; Lichter P; Zapatka M; Seiffert M
Leukemia; 2022 Feb; 36(2):464-475. PubMed ID: 34417556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
